Journal of Parkinson's Disease xx (20xx) x-xx Abstract. Abstract Faecal microbiome transplantation (FMT) is an attractive technique, because the administration is relatively simple and in general has a mild adverse effect pattern. Moreover, FMT consists of a broad mixture, which could be beneficial, because at this moment it is not known what type of changes in the microbiome are needed. However, except from a few cases no clinical data in PD is available yet. There is some indication that FMT might be beneficial in severe constipated patients, but the clinical data to support this are very scarce. So, actually there are no good data in the public domain to support FMT at this moment in Parkinson's disease (PD) patients. FMT at this moment is a black box with too many unanswered questions, also with respect to safety concerns. Administration of species of Lactobacillus and Bifidobacterium over a time period of four to twelve weeks has repeatedly proven to be effective in treating constipation in PD. However, no solid clinical data are available about the possible effects of probiotic treatment on motor symptoms or progression of PD. Therefore, also probiotic treatments in PD should wait until better clinical data become available, in order to select the right target populations and to have good estimates of the clinical effects to be expected. 6 7 8 9 10 11 12 13 14 15 16

